Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bijal Shah

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 12, 2017
Advances in Diagnosis and Management of Diffuse Large B-cell LymphomaFernando Cabanillas, Bijal Shah
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Emerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell TherapyPatrick A Brown, Bijal Shah
Endocrinologia, Diabetes Y Nutricion|February 10, 2023
Thyroid cytology: The reality before and after the introduction of ultrasound classification systems for thyroid nodulesSara Campos Lopes, Bijal Shah, Catarina Eloy
Oncotarget|October 15, 2017
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapyXiaohui Zhang, Prerna Rastogi, Bijal Shah, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
The biological basis for immunotherapy in patients with chronic myelogenous leukemiaJavier Pinilla-Ibarz, Bijal Shah, Jason A Dubovsky
The Annals of Pharmacotherapy|January 3, 2017
Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 DiabetesAlicia Yeh, Bijal Shah-Manek, Kajua B Lor
Journal of Managed Care & Specialty Pharmacy|February 17, 2018
Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National SurveyBijal Shah-Manek, William Wong, Arliene Ravelo, et al.
Oncotargets and Therapy|January 11, 2018
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USAMarco D DiBonaventura, William Wong, Bijal Shah-Manek, et al.
Public Health Reports (Washington, D.C. : 1974)|February 11, 2016
A Comparison of Parallel and Integrated Models for Implementation of Routine HIV Screening in a Large, Urban Emergency DepartmentAbigail Hankin, Heather Freiman, Brittney Copeland, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Value Frameworks for the Patient-Provider Interaction: A Comparison of the ASCO Value Framework Versus NCCN Evidence Blocks in Determining Value in OncologyBijal Shah-Manek, Joseph S Galanto, Huong Nguyen, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|November 12, 2017
Advances in Diagnosis and Management of Diffuse Large B-cell LymphomaFernando Cabanillas, Bijal Shah
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Emerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell TherapyPatrick A Brown, Bijal Shah
Endocrinologia, Diabetes Y Nutricion|February 10, 2023
Thyroid cytology: The reality before and after the introduction of ultrasound classification systems for thyroid nodulesSara Campos Lopes, Bijal Shah, Catarina Eloy
Oncotarget|October 15, 2017
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapyXiaohui Zhang, Prerna Rastogi, Bijal Shah, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
The biological basis for immunotherapy in patients with chronic myelogenous leukemiaJavier Pinilla-Ibarz, Bijal Shah, Jason A Dubovsky
The Annals of Pharmacotherapy|January 3, 2017
Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 DiabetesAlicia Yeh, Bijal Shah-Manek, Kajua B Lor
Journal of Managed Care & Specialty Pharmacy|February 17, 2018
Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National SurveyBijal Shah-Manek, William Wong, Arliene Ravelo, et al.
Oncotargets and Therapy|January 11, 2018
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USAMarco D DiBonaventura, William Wong, Bijal Shah-Manek, et al.
Public Health Reports (Washington, D.C. : 1974)|February 11, 2016
A Comparison of Parallel and Integrated Models for Implementation of Routine HIV Screening in a Large, Urban Emergency DepartmentAbigail Hankin, Heather Freiman, Brittney Copeland, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Value Frameworks for the Patient-Provider Interaction: A Comparison of the ASCO Value Framework Versus NCCN Evidence Blocks in Determining Value in OncologyBijal Shah-Manek, Joseph S Galanto, Huong Nguyen, et al.
Pageof 13